Page not found

×

Warning message

Your search used too many AND/OR expressions. Only the first 7 terms were included in this search.

Search results

  1. Vanderbilt study suggests way to prevent rare lung disease

    ... and also by giving a drug that blocked signaling through a serotonin receptor called 5-HT2B. “We were quite surprised to find out that ...

    sommers - 02/21/2019 - 9:51am

  2. Potential schizophrenia treatment, discovered at Vanderbilt and being developed by Neumora Therapeutics, entering Phase 1 clinical trial

    ... research collaboration agreement for two novel series of M4 receptor modulator compounds, including NMRA-266, in  February  2022.  ... collaboration was facilitated by the   Center for Technology Transfer and Commercialization . Vanderbilt researchers who ...

    sommers - 01/17/2024 - 10:08am

  3. Twelve at Vanderbilt are among world’s highly cited researchers

    ... therapeutics, including monoclonal antibodies, to treat and prevent viral disease. De-en Jiang , PhD, professor of Chemical and Biomolecular ... and guidelines aimed at decreasing the progression of heart failure. ...

    sommers - 11/20/2023 - 8:59am

  4. Discovery Vanderbilt invests in three faculty-initiated startups: HeroWear, IDBiologics and Virtuoso

    ... the  Center for Rehabilitation Engineering and Assistive Technology  by  Karl Zelik , associate professor of mechanical ... development as novel medicines that could treat COVID-19 or prevent infection from the SARS-CoV-2 virus.   Today, IDBiologics ...

    sommers - 05/23/2023 - 12:14pm

  5. “Ultra-potent” antibody against COVID-19 variants isolated at VUMC

    09/27/2021 A technology developed at Vanderbilt University Medical Center has led to the ... anticipates future outbreaks before they occur is needed to prevent a repeat of COVID-19, “or something worse happening in the future,” ... before. LIBRA-seq  stands for Linking B-cell Receptor to Antigen Specificity through sequencing. It was developed in 2019 by ...

    sommers - 09/28/2021 - 9:45am

  6. Antibody “road block” enables fine-tuning for cardiac recovery, decreases risk of heart failure

    ... year experience myocardial infarction, commonly known as a heart attack, as well as the healing and rebuilding phase that begins shortly ... how this particular antibody could target cadherin-11 to prevent  calcific aortic valve disease . “Some amount of inflammation ...

    sommers - 09/20/2019 - 2:20pm

  7. Tech Connect, Vol. 7, Issue 14: Vanderbilt Cardiac Innovations

    ... as positive allosteric modulators of muscarinic acetycholine receptor M1 9,545,385    Inhibitors of hemeprotein-catalyzed lipid ... Technology Spotlight: Near-Infrared Dye with Large Stokes ...

    steelmk - 07/21/2017 - 3:15pm

  8. Tech Connect, Vol. 7, Issue 10: CTTC sponsors Flash Pitch '16

    ... allosteric modulators of the muscarinic acetylcholine receptor M4 9,492,544    Compositions and methods for targeting ... Technology Spotlight: Accurate Gamma‐Ray ...

    steelmk - 07/21/2017 - 3:04pm

  9. From Concept to Commercialization: Dr. Paul Yock

    ... for Biodesign, dedicated to advanced training in medical technology innovation. Join us for an open discussion with Dr. Yock on biodesign, medical technology innovation, and his entrepreneurial journey. Registration is ...

    sommers - 03/25/2024 - 3:02pm

  10. Vanderbilt University School of Medicine ranks in the top 10 for grant support provided by the NIH in FY23

    ... pandemic, the emergency diagnosis and management of acute heart failure and delirium in an aging U.S. population and reliably and safely ...

    sommers - 03/18/2024 - 9:26am